[1] Xu Z Y, Hu C, Chen S, et al.Evaluation of D2-plus radical resection for gastric cancer with pyloric invasion[J]. BMC Surgery, 2019, 19(1):172. [2] Kumagai K, Sano T, Hiki N, et al.Survival benefit of “D2-plus” gastrectomy in gastric cancer patients with duodenal invasion[J]. Gastric Cancer, 2017,21(2):296-302. [3] Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition)[J]. Gastric Cancer, 2021, 24(1):1-21. [4] Sun W, Deng J, Zhang N, et al.Prognostic impact of D2-plus lymphadenectomy and optimal extent of lymphadenectomy in advanced gastric antral carcinoma: Propensity score matching analysis[J]. Chin J Cancer Res, 2020, 32(1):51-61. [5] Marrelli D, F Ferrara, Giacopuzzi S, et al. Incidence and Prognostic Value of Metastases to “Posterior” and Para-aortic Lymph Nodes in Resectable Gastric Cancer[J]. Ann Surg Oncol, 2017, 24(8):2273-2280. [6] Yu P, Du Y, Xu Z, et al.Comparison of D2 and D2 plus radical surgery for advanced distal gastric cancer: A randomized controlled study[J]. J Clin Oncol, 2019, 37(15):15546-15551. [7] 陈路川, 魏晟宏, 叶再生,等. 进展期胃癌No.8p淋巴结转移的危险因素及预后分析[J]. 中华胃肠外科杂志, 2017, 20(2):218-223. [8] 叶再生, 曾奕, 魏晟宏,等. 进展期胃癌No.8p淋巴结清扫的可行性[J]. 中华胃肠外科杂志, 2018, 21(10):1129-1135. [9] 何显力, 吴涛. 4K腹腔镜远端胃癌根治术淋巴结清扫范围规范及技术标准解读[J]. 中华消化外科杂志, 2020, 19(7):16-20. [10] 中国医师协会内镜医师分会腹腔镜外科专业委员会,中国研究型医院学会机器人与腹腔镜外科专业委员会,中国腹腔镜胃肠外科研究组. 中国腹腔镜胃癌根治手术质量控制专家共识(2017版)[J]. 中华消化外科杂志, 2017, 16(6):539-547. |